Literature DB >> 24491679

Autoantibodies to complement components in C3 glomerulopathy and atypical hemolytic uremic syndrome.

Mihály Józsi1, Stefanie Reuter2, Pilar Nozal3, Margarita López-Trascasa4, Pilar Sánchez-Corral5, Zoltán Prohászka6, Barbara Uzonyi7.   

Abstract

The alternative pathway of complement is implicated in the pathogenesis of several renal diseases, such as atypical hemolytic uremic syndrome, dense deposit disease and other forms of C3 glomerulopathy. The underlying complement defects include genetic and/or acquired factors, the latter in the form of autoantibodies. Because the autoimmune forms require a specific treatment, in part different from that of the genetic forms, it is important to detect the autoantibodies as soon as possible and understand their characteristics. In this overview, we summarize the types of anti-complement autoantibodies detected in such diseases, i.e. autoantibodies to factor H, factor I, C3b, factor B and those against the C3 convertases (C3 nephritic factor and C4 nephritic factor). We draw attention to newly described autoantibodies and their characteristics, and highlight similarities and differences in the autoimmune forms of these diseases.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atypical hemolytic uremic syndrome; Autoantibodies; C3 convertase; C3 glomerulopathy; C3 nephritic factor; Complement regulation; Factor B; Factor H; Kidney disease

Mesh:

Substances:

Year:  2014        PMID: 24491679     DOI: 10.1016/j.imlet.2014.01.014

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  19 in total

Review 1.  Complementopathies.

Authors:  Andrea C Baines; Robert A Brodsky
Journal:  Blood Rev       Date:  2017-02-06       Impact factor: 8.250

2.  Detection of Complement Factor B Autoantibodies by ELISA.

Authors:  Mihály Józsi; Barbara Uzonyi
Journal:  Methods Mol Biol       Date:  2021

Review 3.  [Membranoproliferative glomerulonephritis and C3 glomerulopathy].

Authors:  B Hohenstein; K Amann; J Menne
Journal:  Internist (Berl)       Date:  2019-05       Impact factor: 0.743

Review 4.  Anti-complement-factor H-associated glomerulopathies.

Authors:  Marie-Agnes Dragon Durey; Aditi Sinha; Shambhuprasad Kotresh Togarsimalemath; Arvind Bagga
Journal:  Nat Rev Nephrol       Date:  2016-07-25       Impact factor: 28.314

5.  Clinical and functional consequences of anti-properdin autoantibodies in patients with lupus nephritis.

Authors:  M Radanova; G Mihaylova; D Ivanova; M Daugan; V Lazarov; L Roumenina; V Vasilev
Journal:  Clin Exp Immunol       Date:  2020-05-07       Impact factor: 4.330

6.  Functional Characterization of Autoantibodies against Complement Component C3 in Patients with Lupus Nephritis.

Authors:  Vasil V Vasilev; Remi Noe; Marie-Agnes Dragon-Durey; Sophie Chauvet; Valentin J Lazarov; Boriana P Deliyska; Veronique Fremeaux-Bacchi; Jordan D Dimitrov; Lubka T Roumenina
Journal:  J Biol Chem       Date:  2015-08-05       Impact factor: 5.157

Review 7.  The Immunopathology of Complement Proteins and Innate Immunity in Autoimmune Disease.

Authors:  Federica Defendi; Nicole M Thielens; Giovanna Clavarino; Jean-Yves Cesbron; Chantal Dumestre-Pérard
Journal:  Clin Rev Allergy Immunol       Date:  2020-04       Impact factor: 8.667

8.  Prevention of Fatal C3 Glomerulopathy by Recombinant Complement Receptor of the Ig Superfamily.

Authors:  Xiaoxu Wang; Menno Van Lookeren Campagne; Kenneth J Katschke; Damodar Gullipalli; Takashi Miwa; Yoshiyasu Ueda; Yuan Wang; Matthew Palmer; Guolan Xing; Wen-Chao Song
Journal:  J Am Soc Nephrol       Date:  2018-06-12       Impact factor: 10.121

9.  Serum properdin consumption as a biomarker of C5 convertase dysregulation in C3 glomerulopathy.

Authors:  F Corvillo; M Bravo García-Morato; P Nozal; S Garrido; A Tortajada; S Rodríguez de Córdoba; M López-Trascasa
Journal:  Clin Exp Immunol       Date:  2016-01-22       Impact factor: 4.330

Review 10.  Autoimmunity in Acute Poststreptococcal GN: A Neglected Aspect of the Disease.

Authors:  Bernardo Rodriguez-Iturbe
Journal:  J Am Soc Nephrol       Date:  2021-02-02       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.